Mehrdad Toosi is a Cardiology physician. OpenAlex indexes 8 publications with 250 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1110 W Peachtree St NW Ste 920
Atlanta, GA 303093609
Telephone
404-962-6000Provider last certified this registry record 12 Oct 2020.
Industry payments
38 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ancora Heart, Inc.Program year20257 payments
- ABIOMEDProgram year20254 payments
- CVRx, Inc.Program year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.1%Beta blocker18%Carvedilol42%Metoprolol Succinate38%Bisoprolol Fumarate12%Metoprolol Tartrate4%Sotalol4%Part D<11 patientsAldosterone antagonist (MRA)15.5%Spironolactone100%Part D≥103 patients+ 11 more classes in this area
Metabolism & gastrointestinal
14.8%SGLT2 inhibitor12.9%Farxiga57%Jardiance43%Part D≥39 patientsPotassium supplement1.2%Potassium Chloride100%Part D<11 patients+ 1 more class in this area
Blood & clotting
6.5%Factor Xa inhibitor4.3%Eliquis86%Xarelto14%Part D<11 patientsP2Y12 inhibitor2.3%Clopidogrel100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparison of Patients With Peripartum Heart Failure and Normal (≥55%) Versus Low (<45%) Left Ventricular Ejection Fractions
The American Journal of Cardiology
2014 - Is bacteriostatic saline superior to normal saline as an echocardiographic contrast agent?
International journal of cardiac imaging
2014 - Impact of Completeness of Revascularization on Long-Term Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus
Circulation Cardiovascular Interventions
2012 - ‘UnSTEADy'ness in elderly: Unexplained syncope induced by tachycardia in elderly with AV nodal disease and LV diastolic dysfunction
International Journal of Cardiology
2011 - IMPACT OF RESIDUAL MYOCARDIAL JEOPARDY ON LONG-TERM OUTCOME FOLLOWING CORONARY REVASCULARIZATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Journal of the American College of Cardiology
2010
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”